Pre dose concentration [Regulatives / Guidelines]

posted by auditor – India, 2012-02-28 08:59 (3615 d 12:07 ago) – Posting: # 8173
Views: 8,320

Dear All,

As per recent EU guideline for BA/BE, clear statement given for not to withdraw any subject in which >5% Cmax concentration observed after dosing endogenous molecule.

I am looking for such kind of clarity in US FDA guidance. Can any one please let me know is the same thing can be followed in US submission?



Complete thread:

 Admin contact
21,834 posts in 4,569 threads, 1,554 registered users;
online 15 (1 registered, 14 guests [including 7 identified bots]).
Forum time: Friday 21:07 CET (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz